Concepedia

Sekhar Surapaneni

SS

44

Publications

2.9K

Citations

24

H-Index

1994

Active since

Affiliations

Amgen (United States)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Switzerland)

Eli Lilly (United States)

Bristol-Myers Squibb (Germany)

Sekhar Surapaneni is an author at Amgen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1994–2023

44

Publications

44

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Narender R. Gavva, James Treanor, András Garami et al. · Pain · 2008 · 503 citations

, , +15

The Vanilloid Receptor TRPV1 Is Tonically Activated <i>In Vivo</i> and Involved in Body Temperature Regulation

Narender R. Gavva, Anthony W. Bannon, Sekhar Surapaneni et al. · Journal of Neuroscience · 2007 · 308 citations · Full text

The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics

Annette Bak, Anu Gore, Evelyn Yanez et al. · Journal of Pharmaceutical Sciences · 2008 · 216 citations

, , +7

Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade

Narender R. Gavva, Anthony W. Bannon, David N. Hovland et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 170 citations

Characterization and Optimization of AMG 517 Supersaturatable Self‐Emulsifying Drug Delivery System (S‐SEDDS) for Improved Oral Absorption

Ping Gao, Anna Akrami, Francisco J. Álvarez et al. · Journal of Pharmaceutical Sciences · 2008 · 162 citations

, , +7

Rows per page

1–5 of 44